J Med Virol. 2021 Aug 24. doi: 10.1002/jmv.27292. Online ahead of print.
ABSTRACT
Coronavirus disease 2019 (COVID-19) is still propagating a year after the start of the pandemic. Besides the complications patients face during the COVID-19 disease period, there is an accumulating body of evidence concerning the late-onset complications of COVID-19, of which autoimmune manifestations have attracted a remarkable attention from the first months of the pandemic. Autoimmune hemolytic anemia, immune thrombocytopenic purpura, autoimmune thyroid diseases, Kawasaki disease, Guillain-Barre syndrome, and the detection of autoantibodies are of the cues to the discovery of the potentials of COVID-19 in inducing autoimmunity. Clarification of the pathophysiology of COVID-19 injuries to the host, whether it is direct viral injury or the autoimmunity, could help to develop an appropriate treatment. This article is protected by copyright. All rights reserved.
PMID:34427929 | DOI:10.1002/jmv.27292